Home / Expertise / Life Sciences & Healthcare
laboratory shelfs with bottles and vials

Life Sciences & Healthcare

Germany

The CMS Life Sciences und Healthcare Sector Group is made up of over 50 lawyers across Europe, many of whom have specialised in the Life Sciences und Healthcare industry for several years.

The essence of the group's approach is teamwork, working closely as colleagues in Western and Central Europe. The group has complementary expertise in pharmaceutical, biotechnology, medical device, diagnostic and related areas, so can offer pan-European and local, national advice and assistance to the Life Sciences und Healthcare industries.

The group is recognised as having centres of excellence in respect of pharmaceuticals and medical devices in its practices in the United Kingdom, the Netherlands and Germany as well as specialist tax expertise in France.

Services

The CMS Life Sciences und Healthcare Sector Group provides the following comprehensive range of services:

  • Regulatory
  • Pre-clinical and clinical research
  • Collaboration and licensing
  • Financing/M&A stock option schemes
  • Business restructuring
  • Strategic alliances, mergers and acquisitions
  • Distribution and parallel import issues
  • Patent protection and enforcement
  • Branding, trade dress, advertising and labelling
  • Media issues
  • Personal data
  • Product liability and litigation
  • Health and safety
  • EC & competition/competition enforcement
  • Public sector tendering
  • Environment
  • Immigration

Contact

For further information on CMS Life Sciences und Healthcare Sector Group please contact Mr. Jens Wagner.

We are strategic partners of

Young Excellence in healthcare

Young Excellence in Healthcare (YEH) is an interdisciplinary network bringing together young professionals from the healthcare sector. It seeks to develop an intelligent framework for delivering health services in the world of tomorrow. CMS Germany advises YEH strategically and exclusively on all legal matters. CMS also acts as a sounding board for the legal issues and healthcare policies YEH wishes to promote.

Read more Read less

Law Firm of the Year for Healthcare

JUVE Guide, 2018/2019

Choose area

    Care Market

    As the population in Germany ages, care and retirement homes are one of the fastest-growing sectors in the country. As such, they are attracting increasing attention from investors. A major factor here is that demand for care services is largely independent of the economic cycle. The high potential for consolidation in the sector is also a powerful driver: investment in social welfare facilities offers attractive prospects.

    Read more

    Healthcare

    The healthcare sector in Germany is heavily regulated, shaped by a number of very different interests and, above all, subject to constant change. Demographic change is an additional factor – an aging population is increasing the demand for medical services. Players in the healthcare market need to take advantage of existing opportunities, minimise the risks and avoid undesirable developments.

    Read more

    Feed

    Show only
    27 July 2020
    On the Pulse
    Wel­come to ‘On the Pulse’ de­livered by the Glob­al Life Sci­ences & Health­care Sec­tor Group
    20 April 2020
    CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
    Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
    22 July 2020
    Around 1600 view­ers re­gister for live video stream of com­puter soft­ware...
    The En­larged Board of the European Pat­ent Of­fice re­cently heard or­al ar­gu­ments con­cern­ing pat­entab­il­ity of a com­puter soft­ware in­ven­tion. This rare event was video streamed to over 1600 pat­ent stake­hold­ers....
    26 November 2019
    Fu­ture fa­cing life sci­ence and health­care: A wealth of op­por­tun­it­ies, an...
    20 April 2020
    CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
    Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
    14 July 2020
    Santen ends Neur­im-style SPCs
    The word­ing of Art­icle 3(d) of the SPC Reg­u­la­tion re­quires that the SPC ap­plic­a­tion must rely on “the first au­thor­isa­tion to place the product on the mar­ket as a medi­cin­al product”. This sug­gests...
    October 2019
    Health­care M&A
    The re­port cov­ers trans­ac­tion struc­tures, timelines, rep­res­ent­a­tions and war­ranties, due di­li­gence, com­ple­tion is­sues, reg­u­lat­ory frame­work, mer­ger con­trol is­sues, fin­an­cing and valu­ation, pub­lic re­la­tions and gov­ern­ment policy.
    08 July 2020
    “WIPO PROOF”: WIPO’s new on­line ser­vice which helps in­nov­at­ors and cre­at­ors...
    The World In­tel­lec­tu­al Prop­erty Or­gan­isa­tion (WIPO) re­cently launched its new on­line busi­ness ser­vice, “WIPO PROOF”. The plat­form aims to help in­nov­at­ors and cre­at­ors safe­guard their in­tel­lec­tu­al...
    August 2020
    CMS Life Sci­ences & Health­care Glob­al Bro­chure
    02 July 2020
    EU agrees new class ac­tion re­gime for con­sumer dis­putes
    After a long gest­a­tion, on 30 June 2020 the Coun­cil of the EU pub­lished the text for the col­lect­ive re­dress dir­ect­ive (the “CR Dir­ect­ive”) (text avail­able here). This le­gis­la­tion is in­ten­ded to bet­ter...
    August 2019
    Dop­ing is dam­aging es­ports
    26 May 2020
    European Com­mis­sion must ad­dress in­tel­lec­tu­al prop­erty and AI
    The Com­mit­tee on Leg­al Af­fairs (JURI) of the European Par­lia­ment has pub­lished three draft re­ports re­lat­ing to ar­ti­fi­cial in­tel­li­gence (AI). This note is about the draft re­port on in­tel­lec­tu­al prop­erty...